It is not co-expressed with IL17A in the CD4+ T lymphocytes of MS patients [47], and IL22 mRNA is upregulated in circulating cells of relapsing MS patients compared with remitting patients and healthy donors. This evidence concerns the gene IL17A and myeloid sarcoma.